Jaime Ackerman, PA
Physician Assistant · Atlanta, GANPI 1013992544
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Ardelyx, Inc. at 34.6% of the total. 2025 is the largest year on record at $44,326, more than ten times the $4,396 reported in 2021. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 757 payments — averaging $110.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$29K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$27K
- Phathom Pharmaceuticals, Inc.$21K
- AbbVie$3K
- Johnson & Johnson$864
- QOL Medical, LLC$530
- plus $4K from 26 others
What the payments were for
- Consulting fees$18,15422%
- Speaking & faculty fees$36,46443%
- Travel & lodging$15,84719%
- Food & beverage$13,27616%
- Education$1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 70 | $29,058 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 199 | $26,689 |
| Phathom Pharmaceuticals, Inc. | 62 | $20,580 |
| AbbVie | 164 | $2,584 |
| Johnson & Johnson(2 entities) | 43 | $864 |
| QOL Medical, LLC | 18 | $530 |
| Sanofi | 19 | $434 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $391 |
| Lilly USA, LLC | 21 | $380 |
| Bristol Myers Squibb | 28 | $345 |
| Pfizer | 19 | $280 |
| Intercept Pharmaceuticals, Inc. | 13 | $249 |
| Regeneron Healthcare Solutions, Inc. | 10 | $232 |
| Ironwood Pharmaceuticals, Inc | 14 | $226 |
| Nestle Healthcare Nutrition Inc. | 13 | $161 |
| Merck | 6 | $124 |
| Madrigal Pharmaceuticals | 4 | $105 |
| Vivus LLC | 5 | $98 |
| Redhill Biopharma Inc. | 5 | $86 |
| Daiichi Sankyo Inc. | 3 | $78 |
| Enterra Medical, Inc. | 1 | $65 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| Celltrion USA Inc. | 4 | $64 |
| Organon | 3 | $63 |
| Novo Nordisk | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $28 |
| Amgen | 1 | $24 |
| Boehringer Ingelheim | 1 | $24 |
| Evoke Pharma, Inc. | 1 | $18 |
| Merit Medical Systems Inc | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$83,917 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SucraidSacrosidase | 16 | $216,004 |
| CreonLipase/Protease/Amylase | 14 | $49,466 |
| XifaxanRifaximin | 19 | $45,233 |
| LinzessLinaclotide | 26 | $34,441 |
| TrulancePlecanatide | 12 | $15,398 |
| Mesalamine ErMesalamine | 18 | $14,510 |
| Dexlansoprazole DrDexlansoprazole | 34 | $11,406 |
| VoqueznaVonoprazan Fumarate | 16 | $11,114 |
| Pantoprazole Sodium | 580 | $7,648 |
| Mesalamine | 11 | $6,156 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 42 | $5,865 |
| Ursodiol | 21 | $5,618 |
| Lubiprostone | 27 | $5,206 |
| Colesevelam Hcl | 30 | $5,066 |
| Rabeprazole Sodium | 66 | $3,249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| QOL Medical, LLCSucraid | $530 | $216,00416 claims |
| AbbVieCreon, Linzess | $2,584 | $83,90640 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu | $26,689 | $66,49573 claims |
| Phathom Pharmaceuticals, Inc.Voquezna | $20,580 | $11,11416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Atlanta
- Jennifer CobbsAtlanta$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Andrew GoodnerAtlanta$56K
- Tiffany LangemanAtlanta$53K
- Amy SimoneAtlanta$51K
- Rachel NeelyAtlanta$44K
- Jennifer YoungAtlanta$32K
- Kia CampbellAtlanta$20K
- Laura GillespieAtlanta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.